Abstract
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, with almost 1.4 million new cases in 2012. The number of cases is increasing with population growth and ageing. As a result of improved screening, earlier detection, and increased treatment efficacy, relative survival has improved markedly so that CRC is currently the second most prevalent cancer worldwide, with over 3.5 million survivors alive at 5 years after diagnosis. This increasing prevalence, together with substantial differences in individual patients' response to cancer and its treatment and a paucity of rigorous evidence about effective and cost-effective models of service delivery, means that the provision of survivorship care is a major challenge for cancer services.
Survivorship care includes surveillance for recurrent and new cancers, management of late and long term side-effects and secondary prevention. This study investigated received and recommended survivorship care among a population-based sample of colorectal cancer survivors across New South Wales (NSW) as part of the NSW Bowel Cancer Care Study.
Methods: Patients with newly diagnosed colorectal cancer, notified to the NSW Central Cancer Registry between 29 November 2012 and 31 May 2013 and who were 4–6 months post-diagnosis were asked to complete questionnaires on study enrolment and at 12 months post-diagnosis. Questions about experiences of, and preferences for, survivorship care were included in the follow up questionnaire.
Results: Of 1027 patients contacted, 560 participated (55%) at baseline. Respondents had a mean age of 68 years, 60% were male and 28% had rectal cancer. Follow up questionnaires were received from 484 participants (86% of baseline participants, 47% of invited sample). Patterns and predictors of guideline-recommended survivorship care, and patients' preferences for ongoing care, will be presented.
Conclusions: These findings will provide an empirical basis for the development of targeted strategies to improve the implementation of evidence-based survivorship care.
Survivorship care includes surveillance for recurrent and new cancers, management of late and long term side-effects and secondary prevention. This study investigated received and recommended survivorship care among a population-based sample of colorectal cancer survivors across New South Wales (NSW) as part of the NSW Bowel Cancer Care Study.
Methods: Patients with newly diagnosed colorectal cancer, notified to the NSW Central Cancer Registry between 29 November 2012 and 31 May 2013 and who were 4–6 months post-diagnosis were asked to complete questionnaires on study enrolment and at 12 months post-diagnosis. Questions about experiences of, and preferences for, survivorship care were included in the follow up questionnaire.
Results: Of 1027 patients contacted, 560 participated (55%) at baseline. Respondents had a mean age of 68 years, 60% were male and 28% had rectal cancer. Follow up questionnaires were received from 484 participants (86% of baseline participants, 47% of invited sample). Patterns and predictors of guideline-recommended survivorship care, and patients' preferences for ongoing care, will be presented.
Conclusions: These findings will provide an empirical basis for the development of targeted strategies to improve the implementation of evidence-based survivorship care.
| Original language | English |
|---|---|
| Article number | S58 |
| Pages (from-to) | 26 |
| Number of pages | 1 |
| Journal | Asia-Pacific Journal of Clinical Oncology |
| Volume | 10 |
| Issue number | Supplement 7 |
| Publication status | Published - Nov 2014 |
| Externally published | Yes |
| Event | Sydney cancer conference (2014) - Sydney, Australia Duration: 26 Nov 2014 → 28 Nov 2014 |